Rajbhushan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
About Rajbhushan Pharmaceuticals
Rajbhushan Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 December 2017 (Seven years and one month 18 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhushankumar Kadam and Ramchandra Jedhe serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2017PTC100167
-
Company No.
100167
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Dec 2017
-
Date of AGM
05 Jun 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Rajbhushan Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramchandra Jedhe
|
Director | 15-Dec-2017 | Current |
|
Bhushankumar Kadam
|
Director | 15-Dec-2017 | Current |
Financial Performance of Rajbhushan Pharmaceuticals.
Enhance accessibility to Rajbhushan Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajbhushan Pharmaceuticals?
Unlock access to Rajbhushan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Canpex Life Science LlpRamchandra Jedhe is a mutual person
-
Rajbhushan Pharmachem Private LimitedBhushankumar Kadam is a mutual person
-
Orexo (India) Life Sciences Private Limited
Ramchandra Jedhe is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rajbhushan Pharmaceuticals?
Unlock and access historical data on people associated with Rajbhushan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajbhushan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajbhushan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.